Neurostimulation Devices Market Size, Share, Growth Analysis, By Type (Internal Neuromosulation, External Neuromosulation), By Application (Spinal Cord Stimulation, Deep Brain Stimulation), By Region - Industry Forecast 2024-2031

Global Neurostimulation Devices Market size was valued at USD 5.3 Billion in 2022 and is poised to grow from USD 5.98 Billion in 2023 to USD 15.67 Billion by 2031, at a CAGR of 12.80% during the forecast period (2024-2031).

Neurostimulation is a therapeutic technique that utilizes implantable medical devices to regulate and alter neural activity. The devices employed in this process are known as neurostimulators, and the therapy involves delivering electrical impulses to targeted regions of the brain, peripheral nervous system, or spinal cord. Neurostimulation is particularly effective in managing neurological disorders like Parkinson's disease, epilepsy, chronic pain, and depression. It works by providing electrical stimulation that can help alleviate symptoms and enhance the quality of life for patients with conditions such as Parkinson's disease or dystonia, who may experience worsened symptoms due to chronic stress and social restrictions. The market for neurostimulation devices is expanding due to several factors, including an aging population, the development of advanced technologies, increasing use as adjunctive therapy, and the rising prevalence of chronic conditions like migraines and epilepsy. Additionally, high unmet medical needs, the growing burden of neurological disorders, external research funding, and a preference for minimally invasive procedures are driving market growth. For instance, stroke and Alzheimer's disease are major causes of death in the U.S., with Parkinson's disease affecting nearly one million Americans and over 60,000 new cases annually. As the incidence of these diseases rises, the demand for neurostimulation devices is projected to grow. Manufacturers are investing in research to advance these technologies, aiming to offer products that are less invasive, leading to shorter hospital stays and quicker recovery times, which will further propel market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurostimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurostimulation Devices Market Segmental Analysis

The Global Neurostimulation Devices market is segmented by type, Application, and region. Based on type, the market can be segmented into Internal Neuromosulation (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator) External neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), Respiratory Electrical Stimulation (RES)). Based on Application, the market is segmented into Spinal Cord Stimulation (Failed Back Syndrome, Chronic Pain, Ischemia), Deep Brain Stimulation (Parkinson's Disease, Tremor, Depression, Others), Sacral Nerve Stimulation (Urine Incontinence, Fecal Incontinence), Vagus Nerve Stimulation (VNS) (Epilepsy, Others), Gastric Electrical Stimulation (Gastroparesis, Obesity), Transcutaneous Electrical Nerve Stimulation (Treatment-resistant Depression, Others), Transcranial Magnetic Stimulation (Depression, Migraine Headache), Respiratory Electrical Stimulation (Spinal Cord Injury). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurostimulation Devices Market

A major driver of the neurostimulation devices market is the escalating prevalence of neurological disorders globally. According to the World Health Organization, neurological conditions contribute significantly to the global disease burden, impacting millions of individuals. The rising incidence of disorders such as Parkinson's disease, epilepsy, and chronic pain is increasing the demand for neurostimulation devices, which offer effective treatment solutions. This growing need for advanced therapies is prompting manufacturers to invest heavily in research and development to create innovative neurostimulation devices. Such advancements are anticipated to further drive market expansion.

Restraints in the Global Neurostimulation Devices Market

Despite the increasing demand for neurostimulation devices, several factors are hindering market growth. One major restraint is the high cost of these devices, which poses a significant financial burden on patients, particularly in low- and middle-income countries. Additionally, the shortage of skilled healthcare professionals and the limited availability of neurostimulation devices in certain regions further restrict market expansion. Moreover, potential risks related to device implantation, such as infections and device malfunctions, also contribute to market challenges.

Market Trends of the Global Neurostimulation Devices Market

A prominent trend in the neurostimulation devices market is the advancement of minimally invasive and non-invasive technologies. These innovations are increasingly favored due to their benefits over traditional surgical methods, such as reduced pain, shorter hospital stays, and quicker recovery periods. Additionally, the emergence of wireless and implantable devices is contributing to market growth, as they enhance patient comfort by eliminating the need for external wires and bulky equipment. This shift towards less invasive neurostimulation solutions is anticipated to drive continued market expansion in the coming years.